Detailed information
| LncRNA Name | MIAT |
| Variant Type | SNP |
| Variant ID | rs1061451 |
| Species | human |
| Circulating | ✕ |
| Survival | ✕ |
| CeRNA | ✓ |
| Methylation | ✕ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | non-small cell lung cancer |
| LncRNA Target Gene | MYO1B, SGK1 and WNT9A |
| Tissue | cell lines( A549,H1975 ) |
| Experiment | dual luciferase reporter assay; real-time PCR |
| Function Description | C-containing genotypes of MIAT rs1061451 were protective factor of NSCLC, and MIAT, which may act as ceRNA via miR-133a-5p, modulated MYO1B, SGK1 and WNT9A expression level. |
| Pubmed ID | 29795987 |
| Year | 2018 |
| Title | The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer |
| External Links | |
|---|---|
| Links For MIAT | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For non-small cell lung cancer | OMIM Cosmic |
| Links For rs1061451 | dbSNP ClinVar OMIM |